BX Swiss TOP 30 CHF
1.386,27
PKT
+7,48
PKT
+0,54
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.04.12 | ABB (Asea Brown Boveri) neutral | Sarasin Research | |
| 25.04.12 | ABB (Asea Brown Boveri) hold | ING | |
| 25.04.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.04.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 25.04.12 | Novartis hold | Vontobel Research | |
| 25.04.12 | UBS hold | Vontobel Research | |
| 25.04.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 24.04.12 | Novartis buy | WestLB AG | |
| 24.04.12 | Novartis halten | Independent Research GmbH | |
| 24.04.12 | Novartis buy | Sarasin Research | |
| 24.04.12 | Nestlé buy | Sarasin Research | |
| 24.04.12 | Swiss Re buy | Vontobel Research | |
| 24.04.12 | Nestlé halten | Independent Research GmbH | |
| 24.04.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 24.04.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 24.04.12 | Novartis underperform | Cheuvreux SA | |
| 24.04.12 | Swisscom equal-weight | Morgan Stanley | |
| 24.04.12 | Novartis hold | Vontobel Research | |
| 24.04.12 | Nestlé hold | ING | |
| 23.04.12 | Givaudan neutral | Sarasin Research | |
| 23.04.12 | Novartis buy | Nomura | |
| 23.04.12 | Novartis buy | Sarasin Research | |
| 23.04.12 | Nestlé outperform | Cheuvreux SA | |
| 23.04.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 23.04.12 | Nestlé halten | Independent Research GmbH | |
| 20.04.12 | Nestlé buy | Sarasin Research | |
| 20.04.12 | Nestlé hold | ING | |
| 20.04.12 | ABB (Asea Brown Boveri) hold | ING | |
| 18.04.12 | Swiss Re underperform | RBC Capital Markets | |
| 18.04.12 | Swiss Re buy | Sarasin Research | |
| 17.04.12 | Sika neutral | Sarasin Research | |
| 17.04.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 16.04.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 16.04.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 13.04.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.04.12 | UBS underperform | Exane-BNP Paribas SA | |
| 12.04.12 | Roche outperform | Cheuvreux SA | |
| 12.04.12 | Holcim outperform | Cheuvreux SA | |
| 12.04.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 12.04.12 | Holcim underperform | Cheuvreux SA |